ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy

Sambavy Nadaraja*, Doris Schledermann, Jørn Herrstedt, Olga Østrup, Henrik J. Ditzel, On behalf of Academy of Geriatric Cancer Research (AgeCare)

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint

Dive into the research topics of 'ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences